Summit Therapeutics Inc.

Summit Therapeutics Inc.verified

SMMT

Price:

$19

Market Cap:

$14.00B

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cam...[Read more]

Industry

Biotechnology

IPO Date

2015-03-05

Stock Exchange

NASDAQ

Ticker

SMMT

The Current Ratio as of December 2024 (TTM) for Summit Therapeutics Inc. (SMMT) is 8.31

According to Summit Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.31. This represents a change of 23.47% compared to the average of 6.73 of the last 4 quarters.

Summit Therapeutics Inc. (SMMT) Historical Current Ratio (quarterly & annually)

How has SMMT Current Ratio performed in the past?

The mean historical Current Ratio of Summit Therapeutics Inc. over the last ten years is 5.88. The current 8.31 Current Ratio has changed 14.04% with respect to the historical average. Over the past ten years (40 quarters), SMMT's Current Ratio was at its highest in in the June 2023 quarter at 19.07. The Current Ratio was at its lowest in in the September 2020 quarter at 1.44.

Quarterly (TTM)
Annual

Average

5.88

Median

3.92

Minimum

1.89

Maximum

16.93

Summit Therapeutics Inc. (SMMT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Summit Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 345.87%

Maximum Annual Current Ratio = 16.93

Minimum Annual Increase = -52.97%

Minimum Annual Current Ratio = 1.89

Quarterly (TTM)
Annual
YearCurrent RatioChange
20239.30-45.09%
202216.93345.87%
20213.8013.73%
20203.34-46.78%
20196.2772.75%
20193.6391.70%
20181.89-38.08%
20173.06-52.97%
20166.5161.24%
20154.03143.64%

Summit Therapeutics Inc. (SMMT) Average Current Ratio

How has SMMT Current Ratio performed in the past?

The current Current Ratio of Summit Therapeutics Inc. (SMMT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

10.01

5-year avg

7.93

10-year avg

5.88

Summit Therapeutics Inc. (SMMT) Current Ratio vs. Peers

How is SMMT’s Current Ratio compared to its peers?

Summit Therapeutics Inc.’s Current Ratio is less than Nkarta, Inc. (12.91), less than Cullinan Oncology, Inc. (24.46), greater than Kezar Life Sciences, Inc. (7.65), less than Kronos Bio, Inc. (8.32), less than ZyVersa Therapeutics, Inc. (33.83), greater than Ocean Biomedical, Inc. (0.04), less than Zura Bio Limited (10.36), less than Elevation Oncology, Inc. (17.77), less than Icosavax, Inc. (18.06), less than Phio Pharmaceuticals Corp. (0), greater than Sonnet BioTherapeutics Holdings, Inc. (6.38), greater than 180 Life Sciences Corp. (0.66), greater than Cardio Diagnostics Holdings, Inc. (0.19), less than null (8.51),

Build a custom stock screener for Summit Therapeutics Inc. (SMMT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Summit Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Summit Therapeutics Inc. (SMMT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Summit Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Summit Therapeutics Inc.'s Current Ratio?

How is the Current Ratio calculated for Summit Therapeutics Inc. (SMMT)?

What is the highest Current Ratio for Summit Therapeutics Inc. (SMMT)?

What is the 3-year average Current Ratio for Summit Therapeutics Inc. (SMMT)?

What is the 5-year average Current Ratio for Summit Therapeutics Inc. (SMMT)?

How does the current Current Ratio for Summit Therapeutics Inc. (SMMT) compare to its historical average?